HomeMRSN • NASDAQ
add
Mersana Therapeutics Inc
Previous close
$3.15
Day range
$3.17 - $3.32
Year range
$0.80 - $9.62
Market cap
388.17M USD
Avg Volume
2.11M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 10.70M | -27.14% |
Operating expense | 10.13M | -31.55% |
Net income | -19.54M | 56.50% |
Net profit margin | -182.64 | 40.29% |
Earnings per share | -0.16 | 64.09% |
EBITDA | -20.48M | 55.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 209.08M | -25.52% |
Total assets | 226.06M | -32.39% |
Total liabilities | 189.16M | -21.93% |
Total equity | 36.90M | — |
Shares outstanding | 121.30M | — |
Price to book | 10.16 | — |
Return on assets | -21.40% | — |
Return on capital | -66.51% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -19.54M | 56.50% |
Cash from operations | -31.96M | 37.61% |
Cash from investing | 20.15M | 144.35% |
Cash from financing | 92.00K | -99.78% |
Net change in cash | -11.72M | 78.76% |
Free cash flow | -12.45M | 75.30% |
About
Founded
2001
Website
Employees
123